Home Alzheimer’s Disease Study Aims to Evaluate JZP-458 in ALL/Lymphoblastic Lymphoma Subgroup

Study Aims to Evaluate JZP-458 in ALL/Lymphoblastic Lymphoma Subgroup

A phase II/III study of JZP-458 in patients with acute lymphoblastic leukemia (ALL)/lymphoblastic lymphoma (LBL) who are hypersensitive to E. coli-derived asparaginases was announced at the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program. 

The pivotal, open-label, multicenter, dose confirmation, and pharmacokinetic (PK) study (NCT04145531) is enrolling those who have ≥1 course of asparaginase remaining in their treatment plan. Thereafter, 6 doses of JZP-458 will be substituted for each remaining course. Treatment duration will depend on the number of asparaginase courses remaining in the treatment plan. 

“The inability to receive asparaginase second to hypersensitivity has been associated with poor patient outcomes,” Luke Maese, DO, assistant professor at the University of Utah School of Medicine in the Division of Pediatric Hematology/Oncology,…

Continue Reading to the Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Reflections on Living With an Incurable Illness : braincancer

(I’ve checked with the moderators to make sure this is appropriate and a good fit for this subreddit. I'm a very private person, and...

This Foramen Magnum Meningioma almost killed me 18 years ago.

submitted by /u/dkrem Continue Reading to the Source

Patients, Family & Friends, and Healthcare professionals : braincancer

I am currently a PhD student based at the Marie Curie Palliative Care Research Centre at Cardiff University. My PhD is focussed on developing...

32 year old singer Tom Parker of The Wanted diagnosed with stage 4 glioblastoma

submitted by /u/Jexlan Continue Reading to the Source

Recent Comments